Pitt Shield

Blood-cerebrospinal fluid barrier opening by modified single pulse transcranial focused shockwave.

Authors: Kung Y, Wu CH, Lin MT, Liao WH, Chen WS, Hsiao MY

Transcranial focused shockwave (FSW) is a novel noninvasive brain stimulation that can open blood-brain barriers (BBB) and blood-cerebrospinal fluid barriers (BCSFB) with a single low-energy (energy flux density 0.03 mJ/mm<sup>2</sup>) pulse and low-dose microbubbles (2 × 10<sup>6</sup>/kg). Similar to focused ultrasound, FSW deliver highly precise stimulation of discrete brain regions with adjustable focal lengths that essentially covers the whole brain. By opening the BCSFB, it allows for rapid widespread drug delivery to the whole brain by cerebrospinal fluid (CSF) circulation. Although no definite adverse effect or permeant injury was noted in our previous study, microscopic hemorrhage was infrequently observed. Safety concerns remain the major obstacle to further application of FSW in brain. To enhance its applicability, a modified single pulse FSW technique was established that present 100% opening rate but much less risk of adverse effect than previous methods. By moving the targeting area 2.5 mm more superficially on the left lateral ventricle as compared with the previous methods, the microscopic hemorrhage rate was reduced to zero. We systemically examine the safety profiles of the modified FSW-BCSFB opening regarding abnormal behavior and brain injury or hemorrhage 72 hr after 0, 1, and 10 pulses of FSW-treatment. Animal behavior, physiological monitor, and brain MRI were examined and recorded. Brain section histology was examined for hemorrhage, apoptosis, inflammation, oxidative stress related immunohistochemistry and biomarkers. The single pulse FSW group demonstrated no mortality or gross/microscopic hemorrhage (<i>N</i> = 30), and no observable changes in all examined outcomes, while 10 pulses of FSW was found to be associated with microscopic and temporary RBC extravasation (<i>N</i> = 6/30), and abnormal immunohistochemistry biomarkers which showed a trend of recovery at 72 hrs. The results suggest that single pulse low-energy FSW-BCSFB opening is effective, safe and poses minimal risk of injury to brain tissue (Sprague Dawley, SD rats).

Introduction

Purpose Drug delivery with BBB opening
Study Objective To assess the safety of a modified single-pulse transcranial focused shockwave technique (targeting moved 2.5 mm more superficially) for opening the blood–cerebrospinal fluid barrier in rats by evaluating behavioral, physiological, MRI, and histological outcomes after 0, 1, and 10 pulses.
Animal model / Human subject rat, Sprague Dawley, none, none
Disease model healthy
Targeted brain region(s) lateral ventricle

Outcomes and Safety

Summary of Outcomes Single-pulse FUS opened the BCSFB without damage, while multiple pulses caused transient injury.
Duration of biological effect 2 h
Safety-related matter Single pulse caused no damage; multiple pulses induced transient hemorrhage and inflammation.

Brain Region

Ultrasound Parameters

Ultrasound instrument focused ultrasound transducer
FUS Frequency not reported
FUS Intensity not reported
FUS Pressure 5.4 MPa
FUS Mode pulsed
Pulse duration not reported
Duration of a single FUS session not reported
Focal Characteristics 2.5 mm
Treatment frequency single and multiple

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search